About Jack Hoppin
Jack Hoppin is chairman and CEO of Ratio Therapeutics, a Boston radiopharmaceutical company he co-founded, and a director of Sentonix. He also sits on the boards of Emit Imaging, which he co-founded and chairs, and LumaBridge.
He co-founded the imaging company Invicro in 2008 and ran it as CEO until 2019, then was president of Konica Minolta Precision Medicine until 2021. Earlier he was vice president of imaging systems at Bioscan. He was a founding member of Cerveau Technologies and of Sentonix, and he sat on the board of Noria Therapeutics from 2019 until Bayer bought it in 2021.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Jack Hoppin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jack Hoppin works with at each company, as listed on that company's latest Form D.
Jack Hoppin in the News
- Ratio Therapeutics Announces the Appointment of Kenan Turnacioglu to its Board of Directors
- Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure
- Ratio raises $50M as radiopharma field finds its groove
- Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine